HBS-201

Harmony Biosciences Management, Inc. · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	HBS-201
Also known as	pitolisant delayed-release (DR), pitolisant hydrochloride
Sponsor	Harmony Biosciences Management, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study of HBS-201 (Pitolisant Delayed-release) (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

HBS-201 CI brief — competitive landscape report
HBS-201 updates RSS · CI watch RSS
Harmony Biosciences Management, Inc. portfolio CI